Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study.
Olivier FakihMaxime DesmaretsBérenger MartinClément PratiDaniel WendlingElisabeth MonnetFrank VerhoevenPublished in: Rheumatology (Oxford, England) (2023)
MACE incidence rates at eight years are low in patients newly benefiting from LTI for AS. Our results support the hypothesis of a protective role of NSAIDs and anti-TNF in cardiovascular risk in these patients.